Editorial - Vol 17: Number 1

Abstract

A new era starts here As we have announced during the last months, 2020 is the year for full open access of the Biomedical and Biopharmaceutical Research journal. A longtime objective is now fulfilled, and it is an evolutionary landmark intending to reach another level of organization and consolidation. To reach this point, a great deal of work was done by a small but dedicated team within the BBR. At this time, we remind ourselves of our independent character, separate from any editorial or industry group, exclusively rooted in the science and education world, and under a non¬profit frame. Additionally, it is important to remember that we are wholeheartedly dedicated to the growth of scientific culture thought made real in our common mother-language within the wide “Lusophone” space. These were the founding purposes, and through them we have been supporting many institutions and individuals, especially in Portugal and Brasil, acting as a “window” that has been expanding since our inception. Our journal is, in fact, already an extraordinary science network, Portuguese – based but currently involving other institutions and individuals from all over the world. Nearly all our published papers reveal original research, most often developed under partnership. Our publication shift is a relevant attribute effectively contributing to the advancement of knowledge, impacting researchers, institutions, communities and cultures. It is not easy to gather editors from very different origins, cultural background, and experiences, but our resulting quality evolution is obvious. We are committed to continuing these objectives, without forgetting our founding principles. The open access of BBR is a determinant milestone. Furthermore, our editorial policy is also in progress, being more adapted to the current future, more attractive, and surely more demanding not only for authors but also for editors and peer-reviewers. We are in fact entering a new era, a new consolidation phase to reach higher quality standards. Thank you to all who, in different forms, made this possible. We are deeply grateful for your generous contributions, and we look forward to working together for a bright future.